Ngā hua rapu - Naveenchandra Suryadevara

Whakamahine hua
  1. 1
    Natural Killer T Cells: An Ecological Evolutionary Developmental Biology Perspective

    Natural Killer T Cells: An Ecological Evolutionary Developmental Biology Perspective mā Amrendra Kumar, Naveenchandra Suryadevara, Timothy Hill, Jelena S. Bezbradica, Luc Van Kaer, Sebastian Joyce

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Heterotypic immunity against vaccinia virus in an HLA-B*07:02 transgenic mousepox infection model

    Heterotypic immunity against vaccinia virus in an HLA-B*07:02 transgenic mousepox infection model mā Amrendra Kumar, Naveenchandra Suryadevara, Kyle J. Wolf, John T. Wilson, Richard J. Di Paolo, James D. Brien, Sebastian Joyce

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    LRRK2 and RIPK2 Variants in the NOD 2-Mediated Signaling Pathway Are Associated with Susceptibility to Mycobacterium leprae in Indian Populations

    LRRK2 and RIPK2 Variants in the NOD 2-Mediated Signaling Pathway Are Associated with Susceptibility to Mycobacterium leprae in Indian Populations mā Patrick Marcinek, Aditya Nath Jha, Vidyagouri Shinde, S. J. Arun, R. Rajkumar, Naveenchandra Suryadevara, Sanjeev Kumar Neela, Hoang Văn Tong, Vellingiri Balachander, Vijaya Lakshmi Valluri, Kumarasamy Thangaraj, Thirumalaisamy P. Velavan

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines

    Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines mā Daniel Shae, Jessalyn J. Baljon, Mohamed Wehbe, Plamen P. Christov, Kyle W. Becker, Amrendra Kumar, Naveenchandra Suryadevara, Carcia S. Carson, Christian R. Palmer, Frances C. Knight, Sebastian Joyce, John T. Wilson

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8<sup>+</sup> Lung-Resident Memory T Cells

    Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8<sup>+</sup> Lung-Resident Memory T Cells mā Frances C. Knight, Pavlo Gilchuk, Amrendra Kumar, Kyle W. Becker, Sema Sevimli, Max E. Jacobson, Naveenchandra Suryadevara, Lihong Wang-Bishop, Kelli L. Boyd, James E. Crowe, Sebastian Joyce, John T. Wilson

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Structural mapping of antibody landscapes to human betacoronavirus spike proteins

    Structural mapping of antibody landscapes to human betacoronavirus spike proteins mā Sandhya Bangaru, Aleksandar Antanasijevic, Nurgun Kose, Leigh M. Sewall, Abigail M. Jackson, Naveenchandra Suryadevara, Xiaoyan Zhan, Jonathan L. Torres, Jeffrey Copps, Alba Torrents de la Peña, James E. Crowe, Andrew B. Ward

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

    Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein mā Naveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, Laura A. VanBlargan, Elad Binshtein, Seth J. Zost, Rachel S. Nargi, Rachel E. Sutton, Emma S. Winkler, Elaine C. Chen, Mallorie E. Fouch, Edgar Davidson, Benjamin J. Doranz, Robert H. Carnahan, Larissa B. Thackray, Michael S. Diamond, James E. Crowe

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Pré-impressão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking

    Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking mā Andrea R. Shiakolas, Kevin J. Kramer, Nicole V. Johnson, Steven C. Wall, Naveenchandra Suryadevara, Daniel Wrapp, Sivakumar Periasamy, Kelsey A. Pilewski, Nagarajan Raju, Rachel S. Nargi, Rachel E. Sutton, Lauren Walker, Ian Setliff, James E. Crowe, Alexander Bukreyev, Robert H. Carnahan, Jason S. McLellan, Ivelin S. Georgiev

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

    Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein mā Naveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, Laura A. VanBlargan, Elad Binshtein, Seth J. Zost, Rachel S. Nargi, Rachel E. Sutton, Emma S. Winkler, Elaine C. Chen, Mallorie E. Fouch, Edgar Davidson, Benjamin J. Doranz, Rita E. Chen, Pei‐Yong Shi, Robert H. Carnahan, Larissa B. Thackray, Michael Diamond, James E. Crowe

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine

    Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine mā Kevin J. Kramer, Erin M. Wilfong, Kelsey Voss, Sierra Barone, Andrea R. Shiakolas, Nagarajan Raju, Caroline E. Roe, Naveenchandra Suryadevara, Lauren Walker, Steven C. Wall, Ariana Paulo, Samuel Schaefer, Debolanle O. Dahunsi, Camille S. Westlake, James E. Crowe, Robert H. Carnahan, Jeffrey C. Rathmell, Rachel H. Bonami, Ivelin S. Georgiev, Jonathan M. Irish

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer

    An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer mā Naveenchandra Suryadevara, Andrea R. Shiakolas, Laura A. VanBlargan, Elad Binshtein, Rita E. Chen, James Brett Case, Kevin J. Kramer, Erica Armstrong, Luke Myers, Andrew Trivette, Christopher Gainza, Rachel S. Nargi, Christopher N. Selverian, Edgar Davidson, Benjamin J. Doranz, Summer M. Diaz, Laura S. Handal, Robert H. Carnahan, Michael Diamond, Ivelin S. Georgiev, James E. Crowe

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition

    Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition mā Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk, Seth J. Zost, Elad Binshtein, Andrea N. Loes, Sarah K. Hilton, John Huddleston, Rachel Eguia, Katharine H. D. Crawford, Adam S. Dingens, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, Paul W. Rothlauf, Zhuoming Liu, Sean P. J. Whelan, Robert H. Carnahan, James E. Crowe, Jesse D. Bloom

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Pré-impressão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

    Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition mā Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk, Seth J. Zost, Elad Binshtein, Andrea N. Loes, Sarah K. Hilton, John Huddleston, Rachel Eguia, Katharine H. D. Crawford, Adam S. Dingens, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, Paul W. Rothlauf, Zhuoming Liu, Sean P. J. Whelan, Robert H. Carnahan, James E. Crowe, Jesse D. Bloom

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface

    Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface mā Seth J. Zost, Jinhui Dong, Iuliia M. Gilchuk, Pavlo Gilchuk, Natalie J. Thornburg, Sandhya Bangaru, Nurgun Kose, Jessica A. Finn, Robin G. Bombardi, Cinque Soto, Elaine C. Chen, Rachel S. Nargi, Rachel E. Sutton, Ryan P. Irving, Naveenchandra Suryadevara, Jonna B. Westover, Robert H. Carnahan, Hannah L. Turner, Sheng Li, Andrew B. Ward, James E. Crowe

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals

    Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals mā Elaine C. Chen, Pavlo Gilchuk, Seth J. Zost, Naveenchandra Suryadevara, Emma S. Winkler, Carly R. Cabel, Elad Binshtein, Rita E. Chen, Rachel E. Sutton, Jessica Rodríguez, Samuel B. Day, Luke Myers, Andrew Trivette, Jazmean K. Williams, Edgar Davidson, Shuaizhi Li, Benjamin J. Doranz, Samuel K. Campos, Robert H. Carnahan, Curtis A. Thorne, Michael Diamond, James E. Crowe

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

    Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein mā Seth J. Zost, Pavlo Gilchuk, Rita E. Chen, James Brett Case, Joseph X. Reidy, Andrew Trivette, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, Elaine C. Chen, Elad Binshtein, Swathi Shrihari, Mario Ostrowski, Helen Y. Chu, Jonathan E. Didier, Keith W. MacRenaris, Taylor Jones, Samuel B. Day, Luke Myers, F. Eun-Hyung Lee, Doan C. Nguyen, Igñacio Sanz, David R. Martinez, Ralph S. Baric, Larissa B. Thackray, Michael Diamond, Robert H. Carnahan, James E. Crowe

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Pré-impressão
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies

    SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies mā Michael Diamond, Rita Chen, Xuping Xie, James Brett Case, Xianwen Zhang, Laura A. VanBlargan, Yang Liu, Jianying Liu, John M. Errico, Emma S. Winkler, Naveenchandra Suryadevara, Stephen Tahan, Jackson S. Turner, Wooseob Kim, Aaron J. Schmitz, Mahima Thapa, David Wang, Andrianus Boon, Dora Pinto, Rachel M. Presti, Jane A. O’Halloran, Alfred H.J. Kim, Parakkal Deepak, Daved H. Fremont, Davide Corti, Herbert W. Virgin, James E. Crowe, Lindsay Droit, Ali H. Ellebedy, Pei‐Yong Shi, Pavlo Gilchuk

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Pré-impressão
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions

    Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions mā Andrea R. Shiakolas, Kevin J. Kramer, Daniel Wrapp, Simone I. Richardson, Alexandra Schäfer, Steven C. Wall, Nianshuang Wang, Katarzyna Janowska, Kelsey A. Pilewski, Rohit Venkat, Robert Parks, Nelia P. Manamela, Nagarajan Raju, Emilee Friedman Fechter, Clinton Holt, Naveenchandra Suryadevara, Rita E. Chen, David R. Martinez, Rachel S. Nargi, Rachel E. Sutton, Julie E. Ledgerwood, Barney S. Graham, Michael Diamond, Barton F. Haynes, Priyamvada Acharya, Robert H. Carnahan, James E. Crowe, Ralph S. Baric, Lynn Morris, Jason S. McLellan, Ivelin S. Georgiev

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals

    Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals mā Seth J. Zost, Pavlo Gilchuk, James Brett Case, Elad Binshtein, Rita E. Chen, Joseph X. Reidy, Andrew Trivette, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, Lauren E. Williamson, Elaine C. Chen, Taylor Jones, Samuel B. Day, Luke Myers, Ahmed O. Hassan, Natasha M. Kafai, Emma S. Winkler, Julie M. Fox, James J. Steinhardt, Kuishu Ren, Yueh–Ming Loo, Nicole L. Kallewaard, David R. Martinez, Alexandra Schäfer, Lisa E. Gralinski, Ralph S. Baric, Larissa B. Thackray, Michael Diamond, Robert H. Carnahan, James E. Crowe

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Pré-impressão
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

    Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19 mā Matthew C. Woodruff, Richard P. Ramonell, Doan C. Nguyen, Kevin S. Cashman, Ankur Singh Saini, Natalie S. Haddad, Ariel M. Ley, Shuya Kyu, J. Christina Howell, Tuğba Öztürk, Saeyun Lee, Naveenchandra Suryadevara, James Brett Case, Regina Bugrovsky, Weirong Chen, Jacob Estrada, Andrea Morrison-Porter, Andrew Derrico, Fabliha A. Anam, Monika Sharma, Henry M. Wu, Sang Le, Scott A. Jenks, Christopher M. Tipton, Bashar S. Staitieh, John L. Daiss, Eliver Ghosn, Michael Diamond, Robert H. Carnahan, James E. Crowe, William T. Hu, F. Eun‐Hyung Lee, Igñacio Sanz

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: